Stanley Tennant, Director at Trovagene, Inc. (TROV), sold 8,334 shares at $0.69 ($6K) on 2017-09-05, disclosed to the SEC on 2017-09-06.
Open-market sale of $6k TROV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TROV | BUY | 2016-12-19 | $21K | — | Filing → |
| TROV | BUY | 2015-08-12 | $61K | — | Filing → |
| TROV | BUY | 2012-12-03 | $121K | — | Filing → |